Previous Article | Next Article 
Journal of Virology, December 2001, p. 11948-11960, Vol. 75, No. 24
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.11948-11960.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Functional Mapping of the DNA Binding Domain of
Bovine Papillomavirus E1 Protein
Michael
West,
David
Flanery,
Kelly
Woytek,
Dhandapani
Rangasamy,
and
Van G.
Wilson*
Department of Medical Microbiology and
Immunology, Texas A&M University System Health Science Center,
College Station, Texas 77843-1114
Received 25 May 2001/Accepted 5 September 2001
 |
ABSTRACT |
Bovine papillomavirus type 1 (BPV-1) requires viral proteins E1 and
E2 for efficient DNA replication in host cells. E1 functions at the BPV
origin as an ATP-dependent helicase during replication initiation.
Previously, we used alanine mutagenesis to identify two hydrophilic
regions of the E1 DNA binding domain (E1DBD), HR1
(E1179-191) and HR3 (E1241-252), which are
critical for sequence-specific recognition of the papillomavirus
origin. Based on sequence and structure, these regions are similar in spacing and location to DNA binding regions A and B2 of T antigen, the
DNA replication initiator of simian virus 40 (SV40). HR1 and A are both
part of extended loops which are supported by residues from the HR3 and
B2
-helices. Both elements contain basic residues which may contact
DNA, although lack of cocrystal structures for both E1 and T antigen
make this uncertain. To better understand how E1 interacts with origin
DNA, we used random mutagenesis and a yeast one-hybrid screen to select
mutations of the E1DBD which disrupt sequence-specific DNA
interactions. From the screen we selected seven single point mutants
and one double point mutant (F175S, N184Y/K288R, D185G, V193M, F237L,
K241E, R243K, and V246D) for in vitro analysis. All mutants tested in
electrophoretic mobility shift assays displayed reduced
sequence-specific DNA binding compared to the wild-type E1DBD. Mutants
D185G, F237L, and R243K were rescued in vitro for DNA binding by the
replication enhancer protein E2. We also tested the eight mutations in
full-length E1 for the ability to support DNA replication in Chinese
hamster ovary cells. Only mutants D185G, F237L, and R243K supported
significant DNA replication in vivo which highlights the importance of
E1DBD-E2 interactions for papillomavirus DNA replication. Based on the
specific point mutations examined, we also assigned putative roles to
individual residues in DNA binding. Finally, we discuss sequence and
spacing similarities between E1 HR1 and HR3 and short regions of two
other DNA tumor virus origin-binding proteins, SV40 T antigen and
Epstein-Barr virus nuclear antigen 1 (EBNA1). We propose that all three
proteins use a similar DNA recognition mechanism consisting of a loop
structure which makes base-specific contacts (HR1) and a helix which
primarily contacts the DNA backbone (HR3).
 |
INTRODUCTION |
Papillomaviruses are members of the
papovavirus family and comprise both human and animal strains. In
addition to causing common cutaneous warts, papillomaviruses can induce
various skin and mucosal lesions (35, 36, 39). Some of
these lesions may progress to malignant carcinomas, depending on the
particular viral strain involved as well as environmental factors.
Malignancies which are highly associated with papillomavirus infection
include laryngeal, cervical, and other anogenital cancers, and it is
noteworthy that human papillomavirus (HPV) types 16, 18, 31, 33, and 45 pose an especially high risk for females, as they are estimated to be
present in at least 90% of cervical cancers (17, 27).
Bovine papillomavirus (BPV) has been used as a model for studying the
biology of papillomavirus replication, particularly the DNA replication
components. Upon entry of a host cell by wounding or abrasion, BPV
replicates its small 8-kb genome to a multicopy episome which is
maintained at steady-state levels of up to several hundred copies per
cell (14). After a steady-state level of replication has
been achieved, the viral DNA then replicates approximately once during
each host cell cycle and is likely regulated by cell cycle controls
(8, 18, 21). In order to initiate viral DNA replication,
the E1 protein forms a multimeric complex with the E2 protein, the
viral origin of replication, and several host cell factors (2, 6,
8, 13, 15, 26, 28, 33). The minimal BPV origin of replication is
approximately 60 bp in length and contains, in order from 5' to 3', a
23-bp AT-rich element, an 18-bp imperfect palindrome which serves as an
E1 binding site, and a 12-bp palindromic E2 binding site
(20).
E1 functions as the initiator of papillomavirus DNA replication in vivo
and plays several roles in this capacity. It is a multifunctional
68-kDa phosphoprotein which cooperates with the E2 protein to bind
sequence-specifically to its cognate E1 binding element in the viral
origin, facilitates origin DNA unwinding by acting as an ATP-dependent
helicase, recruits the host cell DNA polymerase
-primase complex,
which then begins de novo DNA synthesis, and interacts with regulatory
host cell factors such as cyclin E (8, 18, 23, 28, 32,
38). In addition, the phosphorylation state of E1 has been
suggested as a regulatory device and link to the cell cycle control
apparatus, while sumoylation is required for nuclear localization
(8, 18, 19, 21, 24, 25, 39).
How initiation proteins such as E1 recognize and interact with specific
origin sequences is a fundamental question in DNA replication. We
previously demonstrated that an isolated E1 polypeptide, E1121-311, retained specific origin recognition
capacity similar to full-length E1 (16). The origin
recognition activity of E1121-311 indicated that
the double-stranded DNA binding function of E1 resides in an
independent domain that could be investigated in the absence of other
E1 sequences. The precise demarcation of this functional domain has not
yet been established, but the N-terminal boundary must lie near residue
160, as both E1159-303 and
E1162-422 possess origin-binding activity in
vitro while E1162-308 does not (6, 10,
26).
Using alanine mutagenesis of E1121-311 we
identified two short hydrophilic regions, HR1 and HR3, that are
critical for origin binding (12). These results were
consistent with a previous mutational study by Thorner et al. that
identified DNA-binding-negative mutants of E1 mapping to these same
regions (34). By comparison with simian virus 40 (SV40) T
antigen, we suggested that HR1 and HR3 were likely juxtaposed to form
the DNA interaction surface of the E1 DNA binding domain (E1DBD). The
subsequently determined crystal structure for this region confirmed
this prediction and revealed that HR1 was located in a structured loop
region positioned adjacent to
-helix 4, which corresponds to HR3
(Fig. 1) (10). In addition,
the crystal structure revealed an overall conformational similarity
between the E1DBD and the T antigen DBD.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 1.
Summary of E1DBD mutations. (A) E1 amino acid sequence
from residues 150 to 304. The locations of -helices and -sheets
derived from the crystal structure (10) are diagramed
above the sequence, along with the positions of the previously
described hydrophilic regions HR1 and HR3 (12). Below the
sequence are the origin-nonbinding ( row, squares) and origin-binding
(+ row, triangles) mutants from this study (solid symbols) and our
previous study (open symbols). (B) Three-dimensional ribbon diagram of
E1 protein residues 159 to 303 from Enemark et al. (10).
Residues whose mutation yields a nonbinding phenotype in the yeast
one-hybrid assay are indicated in red on the left monomer, and
binding-positive mutations are in blue on the right monomer. The
boundaries of the HR1 loop region are indicated with red arrows, and
the HR3 region boundaries in -helix 4 are indicated with blue
arrows. Specific amino acid positions characterized in detail in the
text are indicated (note that V246 is on the posterior side of
-helix 4 and is not visible in this figure).
|
|
To further define critical residues for E1DBD function, we used a
random mutagenesis procedure and an in vivo yeast one-hybrid screen to
identify nonbinding mutants. The roles of individual residues in E1-DNA
interaction are discussed, and sequence similarities between E1, T
antigen, and EBNA1 are presented.
 |
MATERIALS AND METHODS |
E1DBD mutant library construction.
The yeast expression
construct pGAD424-E1DBD containing E1121-311 has
been described previously (12). Primers 5'GAD424 (5'-CCACTACAATGGATGATGTA-3') and 3'GAD424
(5'-TGCACAGTTGAAGTGAACTTG-3') were used to PCR amplify the
E1DBD region in the presence of the nucleotide analog dITP. A 50-µl
reaction contained 10 mM Tris-HCl (pH 9.0) at 25°C, 50 mM KCl, 0.1%
Triton X-100, 5 mM MgCl2, 200 µM dCTP, 200 µM
dGTP, 200 µM dTTP, 20 µM dATP, 200 µM dITP (Sigma), 50 ng of
template pGAD424-E1DBD, 25 pmol of primer 5'GAD424, 25 pmol of primer
3'GAD424, and 1.25 U of Taq polymerase (Promega). The
reaction was run in an MJR PTC-200 thermocycler and used an initial
denaturation at 94°C for 1 min followed by 30 cycles of 94°C for
15 s, 55°C for 30 s, and 72°C for 1 min. The single PCR product was purified using a Qiaquick gel extraction kit (Qiagen) and
quantified by UV spectroscopy.
A second PCR was run under standard conditions to generate products
lacking dITP. The 50-µl reaction contained 10 mM Tris-HCl
(pH 9.0) at
25°C, 50 mM KCl, 0.1% Triton X-100, 3 mM
MgCl
2, 200
µM dATP, 200 µM dCTP, 200 µM
dGTP, 200 µM dTTP (Sigma), 5 ng of
purified PCR product from the
previous mutagenic reaction, 25
pmol of primer 5'GAD424, 25 pmol of
primer 3'GAD424, and 1.25
U of
Taq polymerase (Promega). The
reaction was run under conditions
identical to the previous reaction.
The single PCR product was
gel extracted, quantified by UV
spectroscopy, and digested with
EcoRI and
SalI
(Roche Molecular Biochemicals). The product was
ligated into pGAD424
which had been cut with
EcoRI and
SalI,
dephosphorylated
with shrimp alkaline phosphatase (Roche Molecular
Biochemicals),
and gel purified. The ligation product was
electroporated into
Escherichia coli (Epicurean Coli
XL1-Blue; Stratagene). Resulting
colonies were scraped into
Luria-Bertani (LB) broth, and plasmid
DNA was extracted with a Qiaprep
spin miniprep kit
(Qiagen).
Evaluation of clones. (i)
-Galactosidase colony-lift filter
assay.
The mutant library plasmid DNA was transformed into yeast
strain YM4271[E1BST-LacZi] (hereafter referred to as YM4271[E1BST]) using a Frozen-EZ Yeast Transformation II kit (Zymo Research). Colonies
were grown at 30°C on synthetic dropout medium plates lacking uracil
and leucine and then lift-transferred onto nitrocellulose filters
(Schleicher & Schuell). Filters were frozen in liquid nitrogen, thawed,
and incubated on top of filter paper soaked in buffer containing 60 mM
Na2HPO4 · 7H2O, 40 mM
NaH2PO4 · H2O, 10 mM KCl, 1 mM
MgSO4 · 7H2O, 0.2%
-mercaptoethanol, and 265 µg of
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-gal) at 30°C for 3 h. The E1DBD open reading frame (ORF) was
sequenced in reporter-negative colonies as described below. Selected
reporter-negative clones were transformed into the control yeast
reporter strain YM4271[p53BLUE] and assayed on nitrocellulose filters
for reporter activity.
(ii) SSCP assay.
Subsequent to filter assays, 60 reporter-positive yeast colonies were cultured and plasmid DNA was
extracted with a Zymoprep yeast plasmid miniprep kit (Zymo Research).
Two sets of primers were used in separate 50-µl PCRs to amplify and
label the 5' and 3' halves of the E1DBD ORF from each clone.
Oligonucleotide primers SSCP1 (5'-CCAAAAAAAGAGATC-3'), SSCP2
(5'-ATGAGATCTTTTTTGC-3'), SSCP3
(5'-GTTTCGAACTCCTAA-3'), and SSCP4
(5'-TTCATAGATCTCTGC-3') were purchased from the Texas A&M
University Veterinary Pathobiology Core Facility. Reactions contained
10 mM Tris-HCl (pH 9.0) at 25°C, 50 mM KCl, 0.1% Triton X-100, 3 mM
MgCl2, 200 µM dATP, 200 µM dCTP, 200 µM
dGTP, 200 µM dTTP (Sigma), 1.25 µl of template plasmid DNA
extracted from yeast, 1.5 pmol of each primer from the SSCP1/SSCP2
primer pair or SSCP3/SSCP4 primer pair (Sigma-Genosys), and 0.25 U of
Taq polymerase (Promega) in a 12.25-µl reaction volume.
Ten microliters of each reaction product was added to 2 µl of
single-strand conformation polymorphism (SSCP) sample buffer, which was
made by combining 9.5 ml of deionized formamide, 0.4 ml of 0.5 M EDTA
(pH 8.0), 0.05 ml of 10% bromophenol blue, and 0.05 ml of 10% xylene
cyanol. Samples were boiled in a water bath for 5 min and immediately
transferred to ice for 2 min. Samples were electrophoresed for 8 h
at 350 V on an 8% polyacrylamide gel containing 5% glycerol and
maintained at 19°C. The gel was dried and imaged using a Molecular
Dynamics Phosphorimager. Samples which exhibited altered gel mobilities
compared to a control were sequenced as described below.
(iii) Temperature-sensitive screens.
The mutant libraries of
pGAD-E1DBD were transformed into yeast strain YM4271[E1BST] and
plated on synthetic dropout medium lacking uracil and leucine. Colonies
were grown at 39°C for 1 week and then assayed for reporter activity
by the filter assay described above. The same colonies were then grown
for 3 additional days at 30°C and examined again for reporter
activity by filter assay. Results at 30 and 39°C were compared, and
colonies which were reporter positive at 30°C and reporter negative
at 39°C were selected. Plasmid DNA was then extracted and sequenced
as described below.
(iv) DNA sequencing.
Yeast colonies were cultured and
plasmid DNA was extracted using a Zymoprep yeast plasmid miniprep kit
(Zymo Research). For reporter-negative clones, PCR was used prior to
DNA extraction to confirm the presence of E1DBD ORF in the plasmid.
After extraction, plasmid DNA was electroporated into E. coli (Epicurean Coli XL1-Blue; Stratagene). The E1DBD ORF was
sequenced using an ABI Big Dye Terminator DNA sequencing kit (PE
Biosystems) with primers against the pGAD424 plasmid, 5'GAD424, and
3'GAD424 (sequences listed above).
Purification of GST-E1DBD and E2 protein.
The E1DBD coding
region from pGAD424-E1DBD mutants F175S, N184Y/K288R, D185G, V193M,
F237L, K241E, R243K, and V246D was subcloned into pGEX-5X-1 (Pharmacia)
using the same EcoRI and SalI sites used to
create the pGAD424-E1DBD mutant library. The subclones were
electroporated into E. coli strain BL21 and
verified by PCR and restriction digestion. Fusion proteins were
purified as previously described (12).
For E2 purification, BL21
E. coli containing pGEX-4T-E2
(expresses glutathione
S-transferase [GST]-E2 fusion
protein with
thrombin cleavage site) was grown in 200 ml of 2XYT broth
containing
100 µg of ampicillin, which was inoculated with a 20-ml
overnight
culture and grown for 3 h at 37°C with shaking at 225 rpm. The
culture was induced with 100 mM IPTG
(isopropylthiogalactopyranoside)
to a final concentration of 1 mM and
grown for another 2 h at
37°C with shaking at 225 rpm. Cells
were centrifuged at 5,000
×
g for 10 min, and the
pellet was frozen at

20°C overnight.
The pellet was thawed for 30 min on ice and resuspended in B-PER
reagent (Pierce) with 5 mM
dithiothreitol (DTT) and 1 mM phenylmethylsulfonyl
fluoride (PMSF).
Lysozyme was added to a concentration of 100
µg/ml, and the
suspension was rotated end over end at 4°C for
1 h. The sample
was sonicated twice for 15 s using an Ultrasonics
sonicator with
the microtip at maximum power and then centrifuged
at 20,000 ×
g for 30 min at 4°C.
Two hundred microliters of glutathione-Sepharose 4B beads (Pharmacia)
was added to the supernatant, which was then rotated
overnight at
4°C. Beads were washed twice with GST-C buffer (50
mM Tris-HCl [pH
7.9], 250 mM NaCl, 5 mM EDTA, 10% glycerol) plus
5 mM DTT and 10 mM
PMSF, twice with GST-E buffer (50 mM Tris-HCl
[pH 8.0], 1 M NaCl, 5 mM EDTA, 10% glycerol) plus 5 mM DTT and
10 mM PMSF, and a final wash
twice in GST-C buffer. GST-E2 bound
to glutathione-Sepharose beads was
cleaved using 5 NIH units of
thrombin in 425 µl of phosphate-buffered
saline overnight at room
temperature. Beads were centrifuged at low
speed, and supernatant
containing cleaved E2 was removed and stored at

20°C. Cleavage
and integrity of the E2 protein were verified by
sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
analysis.
In vitro DNA binding assays.
The concentration of wild-type
GST-E1DBD protein was determined by the Bradford assay
(5). The concentrations of mutant GST-E1DBD proteins were
estimated by Coomassie blue staining of acrylamide gels followed by
densitometry and comparison to a known amount of wild-type protein. In
vitro binding was assessed by a gel shift assay using a blunt-ended,
double-stranded oligonucleotide comprising BPV-1 nucleotides 7926 to 29 as previously described (12, 37). Except where indicated
otherwise, 10 ng of each wild-type or mutant GST-E1DBD protein was used
in the binding assays; where E2 was also included, typically 20 ng of
purified protein was used.
In vivo DNA replication assays.
Mutations were constructed
in heterologous expression vector pCGE1 for expression of full-length
E1 mutants F175S, N184Y, D185G, V193M, F237L, K241E, R243K, and V246D.
Heterologous expression vectors pCGE1 and pCGE2 at 1.0 and 0.1 µg,
respectively, were mixed with 1.0 µg of the BPV origin-containing
vector pBOR or 1.0 µg of pUC18 for positive and negative controls,
respectively. Similar mixtures were made with each pCGE1 mutant, pCGE2,
and pBOR. The combined DNAs were transected into Chinese hamster ovary (CHO) cells using the Lipofectamine transfection reagent (Gibco-BRL). At 48, 72, and 96 h posttransfection, plasmid DNA was harvested by
Hirt extraction and digested with DpnI and
HindIII (New England Biolabs). DNA samples were
electrophoresed on an 8% agarose gel, transferred to a Nytran
Supercharge nylon membrane (Schleicher & Schuell) by Southern transfer,
and cross-linked to the membrane using a Stratalinker (Stratagene). A
pBOR probe was radiolabeled using the Prime-a-Gene labeling system
(Promega) and hybridized to the membrane using Rapid Hyb buffer
(Amersham). The membrane was analyzed by Phosphorimager analysis.
 |
RESULTS |
Mutations in and near HR1 and HR3 decrease E1DBD-dependent reporter
activity in yeast cells.
We previously described the development
of a yeast one-hybrid system for monitoring sequence-specific
interactions of both full-length E1 and the E1DBD with chromosomal DNA
containing three tandem E1 binding sites (E1BST) upstream of the
lacZ gene (12) (Fig.
2A). Reporter gene expression in this
system requires specific E1-E1BS interaction, as neither the pGAD424
parental in the YM4271[E1BST] strain nor the pGAD424-E1DBD construct
in YM4271[p53BLUE] (which contains a p53 binding site instead of the
E1 binding sites) is sufficient for
-galactosidase production.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 2.
Yeast one-hybrid screening system and representative
data. (A) Expression of yeast GAL4 transactivation
domain (GAL4AD) fused to the E1 DNA binding domain (E1DBD) activates a
lacZ reporter gene upon interaction of the E1DBD with
three tandem copies of the E1 binding site (E1BST). (B) Nitrocellulose
filter assay for reporter activity in yeast colonies harboring
pGAD424-E1DBD constructs. YM4271[p53BLUE] is a control strain
containing a p53 binding site in lieu of E1 binding sites, which
confirms that interaction between the E1DBD and E1BST is sequence
specific. Shown are both reporter-positive and reporter-negative
mutants from our screens along with their genotypes. (C) SSCP assay was
used to detect mutations in the E1DBD coding regions of
reporter-positive yeast colonies. PCR was used to amplify and
radiolabel the 5' and 3' halves of the 573-bp E1DBD open reading frame
of wild-type pGAD424-E1DBD and candidate mutants. PCR products were
then processed as described in Materials and Methods and
electrophoresed on native polyacrylamide gels. Samples from the 5' and
3' amplimers are shown in the right and left panels, respectively. Lane
designations are the clone names as listed in Table 2. Lanes marked C
were amplified from the parental wild-type E1DBD clone.
|
|
In order to generate unbiased genetic data of the amino acid
requirements for E1 DNA binding, we generated two libraries of
mutations in the E1DBD ORF by a PCR random mutagenesis procedure
(
31). After cloning the PCR products into pGAD424, the
libraries
were screened using the yeast one-hybrid system, and mutant
clones
which failed to activate the reporter gene, suggesting possible
defects in DNA binding, were isolated (Fig.
2B). Our first library
was
made using limiting amounts of dATP to drive dITP incorporation
and
resulted in clones with an average substitution frequency
that was too
high for easy identification of the critical residues
(Table
1, A clones). Our second library was made
using limiting
dGTP and resulted in a lower substitution frequency of
about one
to two mutations per clone (Table
1, G clones, and Table
2,
BG clones). This second library was
used for the remaining studies
reported here.
Approximately half of 84 reporter-negative colonies that we selected
from filter screens of the second library tested positive
for the E1DBD
insert by PCR, and approximately 65% of the insert-containing
clones
had appropriate restriction digestion profiles. These clones
were
sequenced to identify the mutations present (Table
1), and
the mutant
residues are depicted on the E1DBD structure in Fig.
1. Additionally,
mutant clone G75 (V193M) was isolated in a yeast
two-hybrid screen of
the E1DBD library for mutants which fail
to interact with an E1
fragment, E1
1-311, which normally
interacts with
the wild-type E1DBD (K. Woytek, unpublished data).
This mutant was
subsequently assayed in our yeast one-hybrid system
and failed to
activate the E1DBD-dependent reporter. All mutants
were also
transferred into strain YM4271[p53BLUE] to confirm that
they are
unable to activate the p53-dependent reporter gene by
any spurious
activity.
Considering only single-, double-, and triple-point mutants, we
identified 22 new mutants with 34 amino acid positions altered
and 36 total substitutions. Eleven of 34 positions (34%) mapped
to the HR1
and HR3 regions. However, this number may be an underestimate,
since
some mutations present in double and triple mutants are
likely
nonessential for DNA binding. Consequently, if only single
and double
mutants are considered, we have 19 mutations and can
discount
substitutions at positions 137, 139, and 288 because
137 and 139 are
outside the sequences required for DNA binding
and 288 is functional
when tested separately (not shown). Thus,
we are left with 16 mutations
causing DNA binding defects, of
which 8 (50%) are located in HR1 and
HR3.
Nonessential residues are rare in and near HR1 and HR3.
We
also screened the libraries for binding-functional E1DBD mutants using
two different methods. First, we examined reporter-positive yeast
clones for SSCP. Following plasmid DNA extraction from the yeast
clones, we generated PCR products from the E1DBD ORF, which were then
processed as described in Materials and Methods and examined on native
polyacrylamide gels (Fig. 2C). Of 60 clones screened, 21 (35%) were
found to display SSCP. Second, we used a temperature sensitivity screen
by performing reporter assays at both 30 and 39°C. Using this method,
we screened approximately 300 clones and found four mutant candidates
(1.3%). Upon sequence analysis of clones which displayed conformation
polymorphisms or temperature sensitivity, we identified a variety of
mutations which were scattered throughout the E1DBD (Table 2 and Fig.
1). These binding-functional mutations were largely absent from the HR1
and HR3 regions, with a few exceptions which may represent functional
papillomavirus polymorphisms or simply nonconserved residues (see
Discussion). Furthermore, the paucity of nonsense and frameshift
mutations in reporter-positive clones compared to reporter-negative
clones is consistent with this tested E1 polypeptide being a minimized
DNA binding domain.
From our screens of reporter-positive mutants, we isolated 13 new
mutants with 20 amino acid positions altered and 20 total
substitutions. Between residues 140 and 311, we found 19 mutations,
for
an average of one substitution every nine residues, only one
(5%) of
which mapped to HR1 or HR3, D185N in clone BG14. This
is a conservative
alteration at a residue nonessential for in
vitro DNA binding, as shown
by alanine substitution (
12). Using
a chi-square test with
1 degree of freedom, we compared the frequency
of HR1 and HR3 mutations
in reporter-negative and reporter-positive
clones based on white clones
with 8 of 16 mutations in HR1 or
HR3 and blue clones with 1 of 19 mutations in HR1 or HR3. The
higher number of HR1 and HR3 mutations in
the nonbonding clones
compared to the functional clones was
statistically significant,
with a
P value of <0.005. This
strongly supports the previously
demonstrated importance of these two
regions for origin recognition
by the E1
protein.
HR1- and HR3-associated mutations affect sequence-specific DNA
binding in vitro.
Since we isolated the mutants by in vivo
screening, it was important to test them in vitro for confirmation of
their binding negativity as well as to control protein amounts, which
may vary with expression in vivo. In a previous study we examined five substitution mutants of HR1 (K183A, D185A, K186A, T187A, and T188A) but
only one mutant of HR3 (K241A). Our current yeast screens yielded two
new mutations in HR1 (N184Y and D185G) and three new mutations in HR3
(K241E, R243K, and V246D), which gave us the opportunity to examine HR3
in more depth. In addition, the screen also identified several
nonfunctional mutations which resided outside the HR1 and HR3
sequences. Mutants F175S, V193M, and F237L neighbor HR1 or HR3 and were
chosen for additional study. Mutations at positions 210, 265, and 293 involved adding or removing a proline, which is likely to disrupt
structure, and were not investigated further. Mutation S207C lies in
the
3 helix and may be critical for dimerization of the E1DBD
(10), and will be characterized as part of a later study.
The reporter-negative mutants F175S, N184Y/K288R, D185G, V193M, F237L,
K241E, R243K, and V246D from our yeast screen were
subcloned into pGEX
(Pharmacia) for expression of GST fusion proteins
in
E. coli. The only double mutant included for in vitro study
was
selected because of the presence of substitution K288E in
a
binding-functional mutant (clone BG28, Table
2), which makes
it likely
that N184Y is the mutation critical for DNA binding.
Purified wild-type
and mutant E1DBD proteins were compared for
DNA binding activity using
a radiolabeled oligonucleotide substrate
(BPV nucleotides 7926 to 29)
containing the E1 binding site and
E2 binding site 12. As previously
described, wild-type E1DBD bound
this substrate and produced multiple
E1DBD-DNA complexes (
12).
All E1DBD mutants were observed
to have greatly reduced binding
affinity for the probe compared to the
wild type, confirming the
in vivo results that the mutated residues
were critical for sequence-specific
DNA interaction (Fig.
3). However, mutants D185G, F237L, and
R243K
formed a detectable though still not wild-type level of complex
with the probe at higher protein concentrations (data not shown
and
Fig.
4).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 3.
In vitro analysis of GST-E1DBD interactions with a 50-bp
double-stranded, sequence-specific DNA probe. (A) GST-E1DBD fusion
proteins were purified by glutathione-Sepharose affinity
chromatography. Shown are 10% polyacrylamide gels containing wild-type
and mutant proteins and stained with Coomassie blue. Lanes M, size
markers. (B) Electrophoretic mobility shift assay of wild-type (WT) and
mutant GST-E1DBD fusion proteins. For each reaction, 10 ng of protein
was incubated with the radiolabeled DNA except for mutant V246D, for
which 3 ng was used in this experiment.
|
|

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 4.
In vitro E2-mediated rescue of DNA binding by E1DBD
mutants. Electrophoretic mobility shift assays were performed as in
Fig. 3 using the amounts of proteins (in nanograms) indicated. The
other single-substitution mutations shown in Fig. 3 were all negative
for E2 rescue in this assay (not shown).
|
|
The weak binding activity of these three mutants suggested that they
may still be capable of cooperative interaction with
E2, so the in
vitro DNA binding assays were repeated in the presence
of bacterially
purified E2 (Fig.
4). E1DBD-E2-DNA complexes were
detected for all
three of the mutants, though not for N184Y/K288R,
which does not
exhibit any origin binding in the presence or absence
of E2. These
results indicate, at least in some cases, that protein-protein
interactions between the E1DBD and E2 are sufficient to stabilize
very
poor interactions between the E1DBD and its binding
sequence.
E1DBD mutants positive for E2 interaction support partial in vivo
DNA replication.
The ability of some binding-defective mutants to
be rescued by E2 suggested that they may retain sufficient function to
support DNA replication. Single point mutations F175S, N184Y, D185G,
V193M, F237L, K241E, R243K, and V246D were constructed in the vector pCGE1, which expresses full-length E1 in mammalian cells for in vivo
DNA replication assays. The N184Y mutation was separated from K288R in
this experiment so that substitution at residue 184 was the only change
present in E1. Heterologous expression vectors pCGE1 (wild-type or
mutant) and pCGE2 were transfected along with the BPV-1
origin-containing plasmid pBOR into Chinese hamster ovary cells.
Plasmid DNA was Hirt extracted at 48, 72, and 96 h
posttransfection and examined by Southern blotting as described in
Materials and Methods (Fig. 5A).
DpnI-resistant replication products were quantified by
Phosphorimager analysis, and a minimum of two independent transfections
were performed for each mutant construct. From each experiment,
replication efficiencies were calculated as the percentage of
replication product made in the presence of wild-type E1, and the
average replication efficiencies are plotted in Fig. 5B.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 5.
DNA replication in CHO cells. (A) Representative
Southern blots of replication products recovered from CHO cells at 48, 72, and 96 h posttransfection. Cells were triple transfected at
time zero with vectors for E1 and E2 expression and a plasmid
containing the BPV origin, pBOR, or pUC18 as a non-origin-containing
control. Wild-type (WT) and mutant E1 expression vectors were used as
indicated. (B) Quantitation of DNA replication products. Band
intensities on Southern blots were measured by Phosphorimager analysis.
Replication efficiency of mutant E1 proteins was calculated by
comparing the intensity of wild-type and mutant replication product
bands at 96 h posttransfection. Average replication efficiencies
for two or more independent experiments are shown. Data for V193M were
generated in a separate study.
|
|
Mutants E1
D185G, E1
F237L,
and E1
R243K supported 19, 51, and 72% of
wild-type replication, respectively. In contrast to these
three
mutants, which supported significant levels of DNA replication,
mutants
E1
F175S, E1
N184Y,
E1
V193M, E1
K241E, and
E1
V246D, which
were unable to form E1-E2-DNA
complexes in vitro, supported little
if any replication. Thus, only
those E1DBD mutants which retained
functional interaction with E2 in
vitro could support replication
activity as full-length E1 mutants.
This result is consistent
with the recent report that E2 mutations
which specifically prevent
interaction with the E1DBD also reduce in
vivo DNA replication
(
7,
11).
HR3 is unlikely to make the majority of base contacts with
DNA.
The distribution of functional versus nonfunctional mutations
described above strongly implicates HR1 and HR3 as critical elements
for sequence-specific E1-DNA interaction, but does not discriminate the
individual roles of each element. We noted previously that the
organization of these two E1 elements resembled that of the A and B2
regions of SV40 T antigen, which are similarly critical for
sequence-specific DNA binding (12). The recent crystal
data for the E1DBD confirmed an overall structural similarity between
the T antigen and E1 DNA binding domains (10), and a manual alignment of the primary sequences shows a remarkable
relatedness, particularly in the DNA interaction elements (Fig.
6A).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
(A) Sequence alignment between DNA binding domains of
SV40 T antigen and BPV-1 E1. Boxes indicate regions of sequence
similarity. There is an extended -hairpin in E1 at residues 223 to
230 which is not found in T antigen. The locations of conserved regions
HR1, HR3, A, and B2 are indicated. (B) HR1- and HR3-like elements are
found in origin-binding proteins from three transforming DNA viruses:
papillomavirus, SV40, and Epstein-Barr virus. E1, T antigen (T-AG), and
EBNA1 contain regions of sequence similarity which are separated by
approximately 50 amino acid residues and which are critical for
sequence-specific DNA binding.
|
|
Interestingly, the EBNA1 protein also uses two motifs separated by
approximately 50 residues in the linear sequence, called
the flanking
domain and recognition helix, for specific binding
to an 18-bp sequence
in the Epstein-Barr virus origin (
1,
4,
9). The EBNA1
flanking domain is an extended loop which makes
base contacts, while
the recognition helix makes nonspecific phosphate
contacts
(
4). Thus, EBNA1 achieves sequence-specific DNA binding
using a site-specifying base interactor and a nonspecific phosphate
interactor. Though less distinctive than between E1 and T antigen,
there is intriguing sequence similarity between the EBNA1 flanking
domain and HR1/A, and between the EBNA1 recognition helix and
HR3/B2
(Fig.
6B). In addition to the sequence similarity, the
corresponding
elements have common secondary structures, with
the flanking
domain/HR1/A elements all located in loops while
the distal elements
for all three proteins form helices. These
physical parallels suggest
common functions and implicate HR3
as the DNA backbone binding unit
rather than the base-specific
contact
element.
To assess the functional contribution of HR3 to sequence-specific DNA
binding, we generated a chimeric triple mutant called
THR3 to test for
retention of sequence-specific DNA binding in
the yeast one-hybrid
system (Fig.
7A). THR3 contains three
residues
from T antigen element B2 which were simultaneously
substituted
into E1 HR3 (S242H/E244V/T245S). The rationale for this
construct
was that if HR3 made specific base interactions, then
multiple
amino acid substitution should disrupt the ability to
recognize
the E1BS. Conversely, if the role of HR3 were more in
nonspecific
DNA contact, then substitution with the corresponding
residues
from T antigen should not eliminate binding to the E1BS
sequence.
The results shown in Fig.
7B demonstrate that the mutant
retained
sequence-specific binding capacity in vivo. In a separate
construct,
we also observed that a site-directed single mutation in
HR3,
V246A, functioned in yeast cells (not shown).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 7.
(A) Sequence alignment between E1 HR3 and SV40 T antigen
(TAG) region B2. Also shown is the sequence in the HR3 region of the
THR3 mutant. Multiple site-directed substitutions were made to create
this chimeric mutant of the E1DBD whose HR3 element contains residues
found in the T antigen B2 element. (B) Nitrocellulose filter assay
showing sequence-specific interactions between THR3 and E1 binding
sites in the yeast one-hybrid system. (C) Electrophoretic mobility gel
shift assay as in Fig. 4, showing cooperativity of binding of THR3 with
E2 on an origin-specific DNA probe. Amounts of proteins (in nanograms)
are indicated.
|
|
To further assess the functionality of THR3, the mutant protein was
purified and tested in the in vitro DNA binding assay
(Fig.
7C). While
reduced in activity compared to wild-type E1DBD,
the THR3 protein
demonstrated significant sequence-specific binding
ability and
wild-type levels of E1DBD-E2-DNA complex formation.
Consistent with its
DNA binding properties, in the context of
full-length E1, the THR3
mutations still allowed in vivo replication
at

25% of wild-type
levels (data not shown). Since both THR3
and V246A maintained
sequence-specific DNA binding, residues S242,
E244, T245, and V246 are
not absolutely critical for sequence
specificity of the E1DBD. The
ability to alter the majority of
residues in HR3 without loss of
sequence-specific binding activity
or without complete loss of
replication function is more consistent
with this element's providing
nonspecific contacts than base
recognition.
 |
DISCUSSION |
We previously used site-directed mutagenesis to show that
mutations in E1DBD elements HR1 and HR3 disrupt sequence-specific interaction with the DNA origin. In our current study, we used random
PCR mutagenesis along with a yeast one-hybrid screen to identify
additional mutants of the BPV-1 E1DBD which are defective for
sequence-specific DNA interactions. As a complement, binding-functional mutants were also identified. Our goal in using this nondirected approach was to gain a more extensive understanding of the location and
specific function of those amino acids most important for the
origin-binding activity of E1.
The locations of the various binding-functional and -nonfunctional
mutations are indicated on the E1 sequence and structure in Fig. 1, and
the properties of selected nonbinding mutants are summarized in Table
3. While the mutations were mostly
characterized in the context of the isolated E1DBD, two random and five
site-directed mutations were subsequently analyzed in full-length E1
using the yeast one-hybrid system (data not shown). All seven
mutations, four binding functional and three nonfunctional, had the
same binding phenotypes in the E1DBD compared to full-length E1. Thus, the E1DBD seems to be a truly independent domain in E1, and results with the E1DBD should be generally reflective of the properties of
full-length E1 for DNA interaction.
Residues necessary for sequence-specific DNA binding by E1 are
concentrated in and near HR1 and HR3.
Using the recently published
crystal structure (10), previous studies of T antigen
mutants (29, 30), and our new mutant data, we have arrived
at several conclusions regarding possible functions of specific E1DBD
residues. The first observation to emerge from sequence comparisons of
the E1DBD ORF in reporter-negative yeast clones was the repeated
occurrence of substitutions in and around the HR1 and HR3 regions (Fig.
1). Furthermore, a chi-square statistical test indicated that the
clustering of critical mutations in HR1 and HR3 for the
reporter-negative clones versus the reporter-positive clones had a less
than 0.5% probability of occurring by chance. This correlation is
further evidence that hydrophilic regions HR1 and HR3 are indeed
necessary for sequence-specific DNA binding. Besides the HR1 and HR3
regions, the only other modest clustering of nonfunctional mutations
occurred in
-helix 3. This helix is involved in E1 dimerization, and
the occurrence of several mutations in this region supports an
important functional role for E1-E1 contacts in origin binding. As
expected, functional mutations isolated from the reporter-positive
clones were more evenly distributed throughout the E1DBD.
Role of HR1 residues in E1DBD-DNA interaction.
Our previous
study identified a cadre of hydrophilic residues in HR1 that were
critical for origin binding (12). The recently published
crystal structure of the E1DBD revealed that the HR1 region forms a
structurally well-defined loop which potentially makes
sequence-specific contacts with origin DNA (10). In the current study, two new mutations in HR1 were characterized, N184Y and
D185G. N184Y was analyzed in the context of the double mutant E1DBDN184Y/K288R; however, the K288R substitution
is unlikely to be the critical change for disrupting DNA binding, since
a nonconservative change at this position appeared in a
binding-functional mutant (Table 2). Additionally, the single point
mutant E1N184Y exhibited a severe defect for in
vivo DNA replication in CHO cells. Therefore, the N184Y substitution is
most likely responsible for the defective DNA interaction both in vivo
and in vitro as well as for E2 binding in vitro.
We do not suspect that the N184Y mutation in either E1DBD or
full-length E1 caused severe misfolding, as we observed other
wild-type
activities for the mutant, including nonspecific DNA
binding in the
absence of pUC18 nonspecific competitor DNA and
single-stranded DNA
binding (data not shown). It also seems unlikely
that N184Y would
affect global protein folding, since it is both
a surface residue and
not part of any defined secondary structure
such as an

-helix or

-sheet. However, the majority of E1 proteins
have either a serine or
asparagine at positions corresponding
to 184, suggesting that a polar
side chain able to support hydrogen
bonding is required at this
position. While tyrosine has chemically
similar properties, the much
bulkier tyrosyl group may cause steric
hindrance that would prevent
proper alignment of HR1 with the
base
sequences.
E1DBD
D185G is also severely defective for
sequence-specific DNA binding, but at higher protein concentrations it
does exhibit
some activity. Additionally, this mutant is capable of in
vitro
E2 interaction and supports approximately 20% of the wild-type
E1 in vivo DNA replication. As with N184Y, this partial functionality
again suggests that tertiary structure is not completely disrupted
by
this amino acid change. A previously examined mutation at this
position, E1DBD
D185A, is even less defective and
supports 30 to
50% of wild-type sequence-specific DNA binding
(
12). In the
crystal structure, the side chain of D185
interacts with R243
and contributes to the coupling of HR1 and HR3
(
10). The reduced
but still significant functioning of the
D185A and D185G mutants
indicates that the coordinating bond between
D185 and K243 is
important but not absolutely essential to maintain
correct juxtaposition
of HR1 and HR3; presumably the interaction
between K243 and F182
remains and provides sufficient stability for
modest function.
The more dramatic defect of
E1DBD
D185G compared to the D185A mutant
likely
results from the greater conformational flexibility inherent
in glycine
residues. Thus, the presence of glycine at position
185 may disorder
the loop structure and alter the positioning
of side chains at nearby
residues. This may both disrupt the structurally
stabilizing F182-K243
interaction and disturb possible base-specific
contacts by critical
residues such as K183, N184, K186, and
T187.
Role of HR3 residues in E1DBD-DNA interaction.
We also
isolated and characterized new mutations in the HR3 element. Mutant
K241E was defective for in vivo and in vitro binding, E2 interaction,
single-stranded DNA binding (unpublished data), and in vivo DNA
replication. Residue K241 resides at the N-terminal side of
-helix
4, contributes a positively charged amino group, and lies on the DNA
binding surface of E1. Substitution of a negatively charged glutamic
acid residue likely increases electrostatic repulsion between this
position and the DNA backbone, though this does not exclude that the
lysine might also normally make specific base contacts.
Another mutant, R243K, was interesting and unique because it was
severely crippled for DNA binding despite having a conservative
amino
acid change. Consistently, an earlier study showed that
the same
conservative mutation at the corresponding T antigen
residue, R204
(Fig.
6A), had a severe effect on sequence-specific
DNA binding, more
so than did substitutions at nearby residues
V205 and A207
(
29). Crystal data for the E1DBD show that R243
makes a
total of four contacts, two with the HR1 residues D185
and F182, and
two additional ones with Q264 and L263 (
10). Since
the net
positive charge is unchanged by the lysine substitution,
the most
likely explanation for the functional defect seems to
be the loss of an
amino group. Loss of this moiety effectively
reduces the number of
potential contacts that can be made simultaneously
and likely cripples
this anchoring point for the HR1 region. While
failure to maintain
correct positioning of HR1 and HR3 would explain
the binding defect,
this mutant still formed E1DBD-E2-DNA complexes,
bound single-stranded
DNA (data not shown), and had nearly wild-type
ability to support DNA
replication in vivo. These results are
consistent with retention of a
generally correct tertiary structure
and also suggest that additional
interactions, either from E2
or from other regions of full-length E1,
can somewhat compensate
for the lost contacts at residue 243. Nonetheless, among the E1
proteins from all papillomavirus groups and
the T antigen proteins
from all polyomavirus groups, the arginine 243 position is a highly
conserved residue, which is consistent with its
providing an important
stabilizing
function.
The last mutation in HR3 that was identified by the one-hybrid screen
was V246D. It does not appear that the valine residue
is critical for
specific base contacts, as a V246A mutant was
significantly functional
in vivo (unpublished data). Consequently,
like K241E,
introduction of a negative charge at this V246 may
simply cause
repulsion between this position and the similarly
charged
phosphodiester backbone of the DNA. Alternatively, V246
may actually
help stabilize the DNA contact motifs. The crystal
structure
demonstrates the proximity of residues F237 and V246
in a hydrophobic
pocket just beneath the E1DBD DNA binding surface.
As an F237L mutant
also showed reduced DNA binding in vivo and
in vitro, decreased
hydrophobicity at these residues may affect
nonpolar interactions which
potentially alter HR1 and HR3 positioning.
The potential role of core
hydrophobic residues in architectural
support of the DNA contact motifs
is currently being studied in
more
detail.
To further investigate the role of HR3, a triple substitution mutant,
THR3, was constructed. This mutant retained in vivo
DNA binding
activity, indicating that none of the changed bases,
S242, E244, or
T245, was absolutely essential for sequence-specific
binding. The
ability to replace at least four of the HR3 residues
(THR3 mutations
plus the V246A mutant) without total loss of sequence-specific
recognition function, along with a structural coordination role
for
R243, seems inconsistent for a region designed to make specific
base
contacts with DNA. Therefore, we propose that HR3 is primarily
responsible for making phosphate backbone contacts, like the EBNA1
recognition helix. Such a role would be consistent with the severe
binding defect which resulted from introducing acidic residues
at
positions 241 and 246. In contrast, multiple conserved residues
in HR1
(R180, K183, N184, D185, K186, and T187) are associated
with critical
single point mutations, suggesting that HR1 is a
better candidate for a
sequence recognition
device.
Role of critical residues outside the HR1 and HR3 regions.
Other than substitutions at proline residues (P265 and P293), which
likely severely disrupt overall structure, binding-critical residues
outside HR1 and HR3 fell into two groups: hydrophobic amino acids
(F175, V193, F237, and W277) and residues located in
-helix 3 (F203,
S207, and L210). From the crystal structure, it appears that these
hydrophobic residues may contribute to a core that forms a scaffold
beneath the HR1/HR3 structure and possibly provides an anchor function
for the DNA interaction motif. A more detailed study of the role of
this hydrophobic core will be presented elsewhere (unpublished data).
The

3 helix has been shown to be a functional dimerization interface
for the E1DBD (
10), and we identified two single
substitution
mutations in this region, E1DBD
S207C
and E1DBD
L210P, that were
reporter negative in
the yeast one-hybrid screen. Additionally,
an F203V mutation showed up
in three different reporter-negative
clones, though all had double or
triple mutations, so the contribution
of the F203V mutation to the
functional defect has not been specifically
established. While none of
these single or multiple mutants has
been examined yet in detail, the
occurrence of three different
mutations in this helix suggests a
requisite function in DNA binding.
Thus, these mutants strengthen the
observation that dimerization
of E1 stabilizes origin DNA binding
(
6,
22).
Residues nonessential for DNA binding by E1 occur
throughout E1DBD and are rare in HR1 and HR3 regions.
The
SSCP and temperature sensitivity assays detected yeast clones
expressing binding-functional mutations (Table 2). Most of these DNA
binding-functional mutations were nonconservative, indicating that the
side chains at these positions make little if any contribution to E1DBD
structure. The lack of clustering of nonessential residues is also
consistent with a simple role, such as providing appropriate spacing to
promote proper orientation of essential residues in and near the
critical HR1 and HR3 regions. It should be noted that these residues
may be critical for other functions of the E1DBD, such as interaction
with the E2 protein or host cell replication proteins, but this has not
yet been determined. The only noncritical substitution which did occur
in HR1 or HR3 was D185N in mutant D185N/E258G/F278S. However, this is a
structurally conservative mutation and also can probably maintain the
salt bridge with R243, as discussed above, so it is not surprising that
this substitution was quite functional.
Unfortunately, since the binding-functional mutations that we isolated
are random in nature, interpretations that go beyond
simple
classification of these residues as nonessential for sequence-specific
DNA binding are difficult to make. Thus, while quantification
of
reporter activity for our binding-functional mutants is possible,
definite conclusions about the relative importance of the individual
residues cannot be made without a more extensive site-directed
mutational analysis at each position. It has not escaped our attention
that these mutants could prove useful for studying other functions
associated with the E1DBD besides DNA binding. We currently have
found
one example of a site-directed E1DBD mutation which functions
at
wild-type levels in both DNA binding and E2 interaction but
still fails
in DNA replication (unpublished data). We are now
screening our
randomly generated binding-functional mutants in
DNA replication
assays, and mutants which bind origin DNA but
fail to replicate it
could define functional defects at stages
beyond origin
recognition.
In summary, the results presented here strongly support the roles of
HR1 and HR3 as DNA contact elements for E1 protein. HR1
is part of an
ordered loop structure, while HR3 forms the

4 helix,
and these two
elements are juxtaposed on the surface of the E1DBD
(
10).
Because of the greater tolerance for mutational changes
in HR3 than in
HR1, we propose that HR3 may provide primarily
nonspecific contacts
with the DNA, while HR1 may be the sequence
specificity determinant.
SV40 T antigen has two structurally equivalent
elements, A and B2,
which are also juxtaposed and which show limited
sequence similarity
with the parallel E1 regions. A similar dual
element, loop plus helix,
DNA binding motif also occurs in the
Epstein-Barr virus EBNA1 protein.
In EBNA1 the helix is positioned
so that it can only contact the
sugar-phosphate backbone of the
DNA, while the extended loop makes base
interactions (
3), and
we propose that the equivalent
structures in E1 perform the same
general functions. Thus, all three
origin-binding proteins, E1,
T antigen, and EBNA1, dock with their
palindromic binding sites
using an apparently structurally similar
recognition
mechanism.
 |
ACKNOWLEDGMENTS |
Many thanks to Leemor Joshua-Tor for kindly providing information
about the E1DBD structure during the development of the manuscript.
This work was supported by grant RPG-96-125-05-MBC from the American
Cancer Society.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology and Immunology, Texas A&M University System Health Science Center, College Station, TX 77843-1114. Phone: (979) 845-5207. Fax: 979-845-3479. E-mail: v-wilson{at}tamu.edu.
Present address: Division of Molecular Biology, John Curtin School
of Medical Research, ANU Campus, Canberra City, ACT 2613, Australia.
 |
REFERENCES |
| 1.
|
Ambinder, R. F.,
W. A. Shah,
D. R. Rawlins,
G. S. Hayward, and S. D. Hayward.
1990.
Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA.
J. Virol.
64:2369-2379[Abstract/Free Full Text].
|
| 2.
|
Berg, M., and A. Stenlund.
1997.
Functional interactions between papillomavirus E1 and E2 proteins.
J. Virol.
71:3853-3863[Abstract/Free Full Text].
|
| 3.
|
Bochkarev, A.,
J. A. Barwell,
R. A. Pfuetzner,
E. Bochkareva,
L. Frappier, and A. M. Edwards.
1996.
Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, ebna1, bound to DNA.
Cell
84:791-800[CrossRef][Medline].
|
| 4.
|
Bochkarev, A.,
J. A. Barwell,
R. A. Pfuetzner,
W. Furey,
A. M. Edwards, and L. Frappier.
1995.
Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA1.
Cell
83:39-46[CrossRef][Medline].
|
| 5.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 6.
|
Chen, G., and A. Stenlund.
1998.
Characterization of the DNA-binding domain of the bovine papillomavirus replication initiator E1.
J. Virol.
72:2567-2576[Abstract/Free Full Text].
|
| 7.
|
Chen, G., and A. Stenlund.
2000.
Two patches of amino acids on the E2 DNA binding domain define the surface for interaction with E1.
J. Virol.
74:1506-1512[Abstract/Free Full Text].
|
| 8.
|
Cueille, N.,
R. Nougarede,
F. Mechali,
M. Philippe, and C. Bonne-Andrea.
1998.
Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-CDK2.
J. Virol.
72:7255-7262[Abstract/Free Full Text].
|
| 9.
|
Edwards, A. M.,
A. Bochkarev, and L. Frappier.
1998.
Origin DNA-binding proteins.
Curr. Opin. Struct. Biol.
8:49-53[CrossRef][Medline].
|
| 10.
|
Enemark, E. J.,
G. Chen,
D. E. Vaughn,
A. Stenlund, and L. Joshua-Tor.
2000.
Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus.
Mol. Cell
6:149-158[CrossRef][Medline].
|
| 11.
|
Gillitzer, E.,
G. Chen, and A. Stenlund.
2000.
Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding.
EMBO J.
19:3069-3079[CrossRef][Medline].
|
| 12.
|
Gonzalez, A.,
C. Bazaldua-Hernandez,
M. West,
K. Woytek, and V. G. Wilson.
2000.
Identification of a short, hydrophilic amino acid sequence critical for origin recognition by the bovine papillomavirus E1 protein.
J. Virol.
74:245-253[Abstract/Free Full Text].
|
| 13.
|
Han, Y. F.,
Y. M. Loo,
K. T. Militello, and T. Melendy.
1999.
Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1, and simian virus 40 large T antigen with human replication protein A.
J. Virol.
73:4899-4907[Abstract/Free Full Text].
|
| 14.
|
Howley, P.
1996.
Papillomavirinae: the viruses and their replication, p. 947-978.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fundamental virology. Lippincott-Raven, Philadelphia, Pa.
|
| 15.
|
Lee, D.,
H. Sohn,
G. V. Kalpana, and J. Choe.
1999.
Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
Nature
399:487-491[CrossRef][Medline].
|
| 16.
|
Leng, X.,
J. H. Ludesmeyers, and V. G. Wilson.
1997.
Isolation of an amino-terminal region of bovine papillomavirus type 1 E1 protein that retains origin binding and E2 interaction capacity.
J. Virol.
71:848-852[Abstract/Free Full Text].
|
| 17.
|
Lorincz, A. T.,
R. Reid,
A. B. Jenson,
M. D. Greenberg,
W. Lancaster, and R. J. Kurman.
1992.
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.
Obstet. Gynecol.
79:328-337[Medline].
|
| 18.
|
Ma, T. L.,
N. X. Zou,
B. Y. Lin,
L. T. Chow, and J. W. Harper.
1999.
Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.
Proc. Natl. Acad. Sci. USA
96:382-387[Abstract/Free Full Text].
|
| 19.
|
McShan, G. D., and V. G. Wilson.
1997.
Casein kinase II phosphorylates bovine papillomavirus type 1 E1 in vitro at a conserved motif.
J. Gen. Virol.
78:171-177[Abstract].
|
| 20.
|
McShan, G. D., and V. G. Wilson.
1997.
Reconstitution of a functional bovine papillomavirus type 1 origin of replication reveals a modular tripartite replicon with an essential AT-rich element.
Virology
237:198-208[CrossRef][Medline].
|
| 21.
|
McShan, G. D., and V. G. Wilson.
2000.
Contribution of BPV-1 E1 protein residue 48 to replication function.
J. Gen. Virol.
81:1995-2004[Abstract/Free Full Text].
|
| 22.
|
Mendoza, R.,
L. Gandhi, and M. R. Botchan.
1995.
E1 recognition sequences in the bovine papillomavirus type 1 origin of DNA replication: Interaction between half sites of the inverted repeat.
J. Virol.
69:3789-3798[Abstract/Free Full Text].
|
| 23.
|
Park, P.,
W. Copeland,
L. Yang,
T. Wang,
M. R. Botchan, and I. J. Mohr.
1994.
The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase.
Proc. Natl. Acad. Sci. USA
91:8700-8704[Abstract/Free Full Text].
|
| 24.
|
Rangasamy, D., and V. G. Wilson.
2000.
Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein.
J. Biol. Chem.
275:30487-30495[Abstract/Free Full Text].
|
| 25.
|
Rangasamy, D.,
K. Woytek,
S. A. Khan, and V. G. Wilson.
2000.
SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation.
J. Biol. Chem.
275:37999-38004[Abstract/Free Full Text].
|
| 26.
|
Sarafi, T. R., and A. A. McBride.
1995.
Domains of the BPV-1 E1 replication protein required for origin-specific DNA binding and interaction with the E2 transactivator.
Virology
211:385-396[CrossRef][Medline].
|
| 27.
|
Schiffman, M. H.,
H. M. Bauer,
R. N. Hoover,
A. G. Glass,
D. M. Cadell,
B. B. Rush,
D. R. Scott,
M. E. Sherman,
R. J. Kurman, and S. Wacholder.
1993.
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
J. Natl. Cancer Inst.
85:958-964[Abstract/Free Full Text].
|
| 28.
|
Sedman, J., and A. Stenlund.
1995.
Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro.
EMBO J.
14:6218-6228[Medline].
|
| 29.
|
Simmons, D. T.,
G. Loeber, and P. Tegtmeyer.
1990.
Four major sequence elements of simian virus 40 large T antigen coordinate its specific and nonspecific DNA binding.
J. Virol.
64:1973-1983[Abstract/Free Full Text].
|
| 30.
|
Simmons, D. T.,
K. Wun-Kim, and W. Young.
1990.
Identification of simian virus 40 T antigen residues important for specific and nonspecific binding to DNA and for helicase activity.
J. Virol.
64:4858-4865[Abstract/Free Full Text].
|
| 31.
|
Spee, J. H.,
W. M. de Vos, and O. P. Kuipers.
1993.
Efficient random mutagenesis method with adjustable mutation frequency by use of PCR and dITP.
Nucleic Acids Res.
21:777-778[Free Full Text].
|
| 32.
|
Sun, S.,
L. Thorner,
M. Lentz,
P. MacPherson, and M. Botchan.
1990.
Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein encoded by bovine papillomavirus type 1.
J. Virol.
64:5093-5105[Abstract/Free Full Text].
|
| 33.
|
Swindle, C. S., and J. A. Engler.
1998.
Association of the human papillomavirus type 11 E1 protein with histone H1.
J. Virol.
72:1994-2001[Abstract/Free Full Text].
|
| 34.
|
Thorner, L. K.,
D. A. Lim, and M. R. Botchan.
1993.
DNA-binding domain of bovine papillomavirus type 1 E1 helicase: structural and functional aspects.
J. Virol.
67:6000-6014[Abstract/Free Full Text].
|
| 35.
|
Verdon, M. E.
1997.
Issues in the management of human papillomavirus genital disease.
Am. Fam. Physician
55:1813[Medline].ff.
|
| 36.
|
Wieland, U., and H. Pfister.
1996.
Molecular diagnosis of persistent human papillomavirus infections.
Intervirology
39:145-157[Medline].
|
| 37.
|
Woytek, K. J.,
D. Rangasamy,
C. Bazaldua-Hernandez,
M. West, and V. G. Wilson.
2001.
Effects of mutations within two hydrophilic regions of the BPV-1 E1 DNA binding domain on E1-E2 interactions.
J. Gen. Virol.
82:2341-2351[Abstract/Free Full Text].
|
| 38.
|
Yang, L.,
I. Mohr,
E. Fouts,
D. A. Lim,
M. Nohaile, and M. Botchan.
1993.
The E1 protein of bovine papillomavirus 1 is an ATP-dependent DNA helicase.
Proc. Natl. Acad. Sci. USA
90:5086-5090[Abstract/Free Full Text].
|
| 39.
|
Zanardi, T. A.,
C. M. Stanley,
B. M. Saville,
S. M. Spacek, and M. R. Lentz.
1997.
Modulation of bovine papillomavirus DNA replication by phosphorylation of the viral E1 protein.
Virology
228:1-10[CrossRef][Medline].
|
Journal of Virology, December 2001, p. 11948-11960, Vol. 75, No. 24
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.11948-11960.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Auster, A. S., Joshua-Tor, L.
(2004). The DNA-binding Domain of Human Papillomavirus Type 18 E1: CRYSTAL STRUCTURE, DIMERIZATION, AND DNA BINDING. J. Biol. Chem.
279: 3733-3742
[Abstract]
[Full Text]
-
Titolo, S., Brault, K., Majewski, J., White, P. W., Archambault, J.
(2003). Characterization of the Minimal DNA Binding Domain of the Human Papillomavirus E1 Helicase: Fluorescence Anisotropy Studies and Characterization of a Dimerization-Defective Mutant Protein. J. Virol.
77: 5178-5191
[Abstract]
[Full Text]